Endocidin, created in 2011 (United States), from 9 sister brands and 2214 competing brands. The Endocidin brand is owned by LINEAGE CELL THERAPEUTICS, INC., a company listed in Francfort. Endocidin belongs to the Biotechnology business sector.

Endocidin is a brand of LINEAGE CELL THERAPEUTICS, INC. (BT3) Share price

International deposit : 2011 Business sector Biotechnology

Share price and profitability of the share LINEAGE CELL THERAPEUTICS, INC. (Endocidin)

Buy LINEAGE CELL THERAPEUTICS, INC. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 1.05

Portfolio valuation
LINEAGE CELL THERAPEUTICS, INC. (Endocidin) over 5 years* EUR 1.00

Stock market history LINEAGE CELL THERAPEUTICS, INC. (Endocidin)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
LINEAGE CELL THERAPEUTICS, INC.

Glycosan
Glycosan
Lineage Cell Therapeutics
Lineage Cell Therapeutics
BioTime
BioTime
See more brands of LINEAGE CELL THERAPEUTICS, INC.

Rival brands
Endocidin

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS